Search Results - "Stalenhoef, A F H"

Apolipoprotein B, non‐HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk by Holewijn, S., Den Heijer, M., Swinkels, D. W., H Stalenhoef, A. F., De Graaf, J.

“…  Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AFH, de Graaf J. (Address: Division of Vascular Medicine, Department of General Internal Medicine;…”
Get full text

Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Krüppel-like factor 2 by van Tits, L.J.H, Stienstra, R, van Lent, P.L, Netea, M.G, Joosten, L.A.B, Stalenhoef, A.F.H

“…Abstract Objective Macrophages are key players in atherogenesis because of their properties to form foam cells that produce a large variety of pro-inflammatory…”
Get full text

Brachial artery diameter is related to cardiovascular risk factors and intima-media thickness by Holewijn, S., Den Heijer, M., Swinkels, D. W., Stalenhoef, A. F. H., De Graaf, J.

“…Background  Previous reports showed inconsistent results about the potential role of flow‐mediated dilatation (FMD) in cardiovascular(CV) risk prediction. Few…”
Get full text

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands by Pijlman, A.H, Huijgen, R, Verhagen, S.N, Imholz, B.P.M, Liem, A.H, Kastelein, J.J.P, Abbink, E.J, Stalenhoef, A.F.H, Visseren, F.L.J

“…Abstract Background Heterozygous familial hypercholesterolemia (heFH) is a common autosomal dominant hereditary disorder caused by mutations in the…”
Get full text

Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients by Popa, C, van Tits, L J H, Barrera, P, Lemmers, H L M, van den Hoogen, F H J, van Riel, P L C M, Radstake, T R D J, Netea, M G, Roest, M, Stalenhoef, A F H

“…High-density lipoprotein (HDL) antiatherogenic functions seem to be diminished during inflammatory conditions such as rheumatoid arthritis (RA). The aim of…”
Get more information

The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia by VAN DER VLEUTEN, G. M, KLUIJTMANS, L. A, HIJMANS, A, BLOM, H. J, STALENHOEF, A. F. H, DE GRAAF, J

“…Familial combined hyperlipidemia (FCH) is characterized by elevated levels of total cholesterol (TC), triglycerides (TG) and apolipoprotein B (apo B) and is…”
Get full text

Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised‐controlled trial by DIEPEVEEN, S. H. A., VERHOEVEN, G. W. H. E., VAN DER PALEN, J., DIKKESCHEI, L. D., TITS, L. J., KOLSTERS, G., OFFERMAN, J. J. G., BILO, H. J. G., STALENHOEF, A. F. H.

“… Objectives.  The objective of this study was to examine the effects of treatment with atorvastatin, α‐tocopherol and the combination of both, on lipoproteins…”
Get full text

Silent exonic mutations in the low-density lipoprotein receptor gene that cause familial hypercholesterolemia by affecting mRNA splicing by Defesche, JC, Schuurman, EJM, Klaaijsen, LN, Khoo, KL, Wiegman, A, Stalenhoef, AFH

“…In a large group of patients with the clinical phenotype of familial hypercholesterolemia, such as elevated low‐density lipoprotein (LDL) cholesterol and…”
Get full text

Effect of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidaemia by Ter Avest, E., Abbink, E. J., De Graaf, J., Tack, C. J., Stalenhoef, A. F. H.

“…Background  By influencing the mevalonate pathway, statins may have multiple effects besides lipid lowering. This study was designed to evaluate the effect of…”
Get full text

Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case–control study by van Bommel, E. F. H., van Tits, L. J. H., van den Berg, E. A., Prins, J., Stalenhoef, A. F. H.

“…Chronic periaortitis is thought to result from an autoallergic reaction to oxidized low-density lipoprotein (OxLDL). No data exist on lipid profile and…”
Get full text

Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation by van Tits, L.J.H, Jacobs, E.M.G, Swinkels, D.W, Lemmers, H.L.M, van der Vleuten, G.M, de Graaf, J, Stalenhoef, A.F.H

“…Abstract Background Excess body iron is associated with increased cardiovascular disease risk, possibly via non-transferrin-bound iron (NTBI)-mediated…”
Get full text

Endothelial function in familial combined hyperlipidaemia by Ter Avest, E., Holewijn, S., Van Tits, L. J. H., De Wit, H. M., Stalenhoef, A. F. H., De Graaf, J.

“…Background  Familial combined hyperlipidaemia (FCH) is characterized by dyslipidaemia, visceral obesity and insulin resistance, and is associated with an…”
Get full text

The effect of statin therapy on plasma high‐density lipoprotein cholesterol levels is modified by paraoxonase‐1 in patients with familial hypercholesterolaemia by HIMBERGEN, T. M., TITS, L. J. H., VOORBIJ, H. A. M., GRAAF, J., STALENHOEF, A. F. H., ROEST, M.

“… Objectives.  Statins reduce low‐density lipoprotein cholesterol (LDL‐C) and can raise high‐density lipoprotein cholesterol (HDL‐C). HDL‐bound paraoxonase‐1…”
Get full text

Cholesterol in end-stage renal disease : the good, the bad or the ugly? by DIEPEVEEN, S. H. A, WETZELS, J. F. M, BILO, H. J. C, VAN TITS, L. J. H, STALENHOEF, A. F. H

“…The incidence of cardiovascular disease is markedly increased in patients with end-stage renal disease (ESRD). High serum cholesterol is widely recognised as a…”
Get full text

Morbidity and mortality in first-degree relatives of C282Y homozygous probands with clinically detected haemochromatosis compared with the general population : the HEmochromatosis FAmily Study (HEFAS) by JACOBS, E. M. C, HENDRIKS, J. C. M, MARX, J. J. M, VAN DEURSEN, C. Th. B. M, KREEFTENBERG, H. C, DE VRIES, R. A, STALENHOEF, A. F. H, VERBEEK, A. L. M, SWINKELS, D. W

“…Family screening has been suggested as a sophisticated model for the early detection of HFE-related hereditary haemochromatosis (HH). However, until now,…”
Get full text

Phytosterol consumption and the anabolic steroid boldenone in humans: a hypothesis piloted by Ros, M M, Sterk, S S, Verhagen, H, Stalenhoef, A F H, de Jong, N

“…The presence of the anabolic steroid boldenone in animals has become a research topic as its occurrence is proposed to be a marker for illegal hormone…”
Get more information

Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis by Popa, C, Netea, M G, Radstake, T, Van der Meer, J W M, Stalenhoef, A F H, van Riel, P L C M, Barerra, P

“…Background: Tumour necrosis factor (TNF) is known to increase the concentrations of interleukin (IL) 6 and C reactive protein (CRP) and to induce…”
Get full text

Changing aspects of HFE-related hereditary haemochromatosis and endeavours to early diagnosis by JACOBS, E. M. G, VERBEEK, A. L. M, KREEFTENBERG, H. G, VAN DEURSEN, C. Th. B. M, MARX, J. J. M, STALENHOEF, A. F. H, SWINKELS, D. W, DE VRIES, R. A

“…HFE-related hereditary haemochromatosis (HH) is an iron overload disease attributed to the highly prevalent homozygosity for the C282Y mutation in the HFE…”
Get full text

Effect of plant sterol‐enriched margarine on plasma lipids and sterols in subjects heterozygous for phytosterolaemia by Stalenhoef, A. F. H., Hectors, M., Demacker, P. N. M.

“… Stalenhoef AFH, Hectors M, Demacker PNM (University Medical Centre Nijmegen, Nijmegen, The Netherlands). Effect of plant sterol‐enriched margarine on plasma…”
Get full text

Dominant type III hyperlipoproteinaemia (familial dysbetalipoproteinaemia) by Stalenhoef, A F H

Get full text